Separating the agony from ecstasy: R(–)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
- 6 October 2017
- journal article
- research article
- Published by Elsevier BV in Neuropharmacology
- Vol. 128, 196-206
- https://doi.org/10.1016/j.neuropharm.2017.10.003
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrationsInternational Journal of Neuropsychopharmacology, 2013
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyJournal of Psychopharmacology, 2012
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)Journal of Psychopharmacology, 2012
- Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory StudyPLOS ONE, 2012
- Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) EnantiomersIn Vitroand in the MPTP-Lesioned Primate:R-MDMA Reduces Severity of Dyskinesia, WhereasS-MDMA Extends Duration of ON-TimeJournal of Neuroscience, 2011
- Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in OthersBiological Psychiatry, 2010
- Residual neurocognitive features of long‐term ecstasy users with minimal exposure to other drugsAddiction, 2010
- The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyJournal of Psychopharmacology, 2010
- Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus MonkeysThe Journal of pharmacology and experimental therapeutics, 2010
- MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in micePharmacology Biochemistry and Behavior, 2008